Thein H. Oo MDProfessor of Medicine, Section of Thrombosis and Benign Hematology, University of Texas M.D. Anderson Cancer Center, Houston, Texas
Thein H. Oo received his medical degree from the Institute of Medicine II (now University of Medicine II), Rangoon, Myanmar (Burma). He completed internal medicine training at hospitals recognized by the Royal Colleges of Physicians of UK and at Albany Medical College, New York, USA. He underwent Oncology training at Christie Hospital and Paterson Institute for Cancer Research, Manchester, UK, and Hematology-Oncology Fellowship at Tufts - St Elizabeth’s Medical Center, Tufts University School of Medicine, Boston, USA.
Dr. Oo is currently a Professor of Medicine and Consultant Hematologist in the Section of Thrombosis and Benign Hematology at the University of Texas M.D. Anderson Cancer Center, Houston. His interests include consultative hematology, hemostasis and thrombosis, bone marrow failure syndromes and supportive care in cancer. He participates in many local and national educational and hematology practice activities. He has published over 140 manuscripts, book chapters and abstracts. He currently serves as a Committee Member on the Venous Thromboembolism Network of the United States (VENUS) and on the Hemostasis Study Group of the Multinational Association for Supportive Care in Cancer (MASCC). He previously served as a committee member on the Membership and Communications Committee of the International Society of Thrombosis and Haemostasis, on the Test Material Development Committee and on the Committee on Practice of the American Society of Hematology and as a Senator on the University Faculty Senate.
Recent Contributions to PracticeUpdate:
- Iptacopan Monotherapy in Patients With Paroxysmal Nocturnal Hemoglobinuria
- PE After Removal of CVC Associated With Upper Extremity DVT
- Pernicious Anemia Can Be Treated Effectively With a Single High Dose of Cobalamin
- 2019 International Clinical Practice Guidelines for the Treatment and Prophylaxis of VTE
- VTE Prophylaxis and Treatment in Patients With Cancer
- Risk of Thromboembolic and Bleeding Outcomes Following Hematological Cancers
- Prevention of VTE in Ambulatory Cancer Patients
- MY APPROACH to Prophylaxis for Pelvic Surgery